,
your personalized virtual assistant to find clinical trials. Go head, 
Peter O'Dwyer, MD
Abramson Cancer Center of The ...Philadelphia, Pennsylvania - 19104 (215-662-2812) Abramson Cancer Center at University ...Philadelphia, Pennsylvania - 19104 University of Pennsylvania Abramson Cancer ...Philadelphia, Pennsylvania - 19104 (215-662-7383) Hospital of the University of ...Philadelphia, Pennsylvania - 19104 |
- CLINICAL TRIALS 5
- CONDITIONS20
- INTERVENTIONS11
- SINCE2008
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
September 2010 - September 2012
PD 0332991 in Treating Patients With Refractory Solid Tumors
October 2009 - October 2011
Study of Gemcitabine Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
April 2009 - July 2011
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
August 2009 - January 2011
Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors
November 2008 - July 2010
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Adenocarcinoma
Neoplasms
Neoplasm Metastasis
Ovarian Neoplasms
Carcinoma, Non-Small-Cell Lung
Melanoma
Neoplasms, Germ Cell and Embryonal
Rectal Neoplasms
Colorectal Neoplasms
Cholangiocarcinoma
Breast Neoplasms, Male
Biliary Tract Neoplasms
Germinoma
Seminoma
Teratoma
Testicular Neoplasms
Dermoid Cyst
Pharmacological Study
Bevacizumab
Oxaliplatin
Leucovorin
Hydroxychloroquine
5-Fluorouracil
Pd-0332991
Gemcitabine, Irinotecan, Panitumumab
Mgcd265+Erlotinib
Mgcd265+Docetaxel
Xl888
